Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Southpoint Capital Advisors LP reported a 8.00% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 14, 2026
Southpoint Capital Advisors LP reported a 8.00% stake in Fennec Pharmaceuticals Inc., 2,744,741 shares, as a passive investor on Dec 31, 2025. Filed Jan 14, 2026 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 2,744,741
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Southpoint Master Fund, LP | 8.00% | 2,744,741 |
| Southpoint Capital Advisors LP | 8.00% | 2,744,741 |
| Southpoint Capital Advisors LLC | 8.00% | 2,744,741 |
| Southpoint GP, LP | 8.00% | 2,744,741 |
| Southpoint GP, LLC | 8.00% | 2,744,741 |
| John S. Clark II | 8.00% | 2,744,741 |
Source
Related
- Fennec Pharmaceuticals Inc.
- Southpoint Capital Advisors LP
- Fennec Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Southpoint Capital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026